Regeneron Pharmaceuticals (REGN) Cash from Operations Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 158.60% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.23% |
| Dec 31, 2025 | -7.29% |
| Sep 30, 2025 | 25.36% |
| Jun 30, 2025 | 223.28% |
| Mar 31, 2025 | -30.90% |
| Dec 31, 2024 | 15.89% |
| Sep 30, 2024 | 15.88% |
| Jun 30, 2024 | -65.38% |
| Mar 31, 2024 | 10.60% |
| Dec 31, 2023 | -36.64% |
| Sep 30, 2023 | 77.18% |
| Jun 30, 2023 | 81.15% |
| Mar 31, 2023 | -34.93% |
| Dec 31, 2022 | -27.51% |
| Sep 30, 2022 | -81.58% |
| Jun 30, 2022 | -9.94% |
| Mar 31, 2022 | 214.39% |
| Dec 31, 2021 | 92.73% |
| Sep 30, 2021 | 1,442.35% |
| Jun 30, 2021 | -33.57% |
| Mar 31, 2021 | -4.23% |
| Dec 31, 2020 | 56.34% |
| Sep 30, 2020 | -145.63% |
| Jun 30, 2020 | 401.01% |
| Mar 31, 2020 | -22.19% |
| Dec 31, 2019 | 8.04% |
| Sep 30, 2019 | 23.05% |
| Jun 30, 2019 | -52.28% |
| Mar 31, 2019 | 44.96% |
| Dec 31, 2018 | 28.55% |
| Sep 30, 2018 | 9.18% |
| Jun 30, 2018 | 1,390.81% |
| Mar 31, 2018 | 73.87% |
| Dec 31, 2017 | 45.23% |
| Sep 30, 2017 | -36.28% |
| Jun 30, 2017 | -107.65% |
| Mar 31, 2017 | 691.08% |
| Dec 31, 2016 | 38.52% |
| Sep 30, 2016 | -27.08% |
| Jun 30, 2016 | 54.95% |
| Mar 31, 2016 | 144.23% |
| Dec 31, 2015 | 42.21% |
| Sep 30, 2015 | 443.36% |
| Jun 30, 2015 | -23.36% |
| Mar 31, 2015 | -290.05% |
| Dec 31, 2014 | -29.66% |
| Sep 30, 2014 | 77.73% |
| Jun 30, 2014 | 162.49% |
| Mar 31, 2014 | -37.94% |
| Dec 31, 2013 | 202.33% |
| Sep 30, 2013 | 3,981.40% |
| Jun 30, 2013 | 263.52% |
| Mar 31, 2013 | 199.09% |
| Dec 31, 2012 | 285.20% |
| Sep 30, 2012 | 94.90% |
| Jun 30, 2012 | -130.18% |
| Mar 31, 2012 | -722.69% |
| Dec 31, 2011 | -23.17% |
| Sep 30, 2011 | -128.94% |
| Jun 30, 2011 | -187.34% |
| Mar 31, 2011 | -10.46% |
| Dec 31, 2010 | 11.97% |
| Sep 30, 2010 | 1,744.28% |